Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.655 USD | -13.58% | -21.36% | -36.55% |
04-08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 | |
04-08 | North American Morning Briefing : Inflation Data, -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.55% | 93.15M | |
+3.32% | 108B | |
+11.11% | 104B | |
+1.28% | 22.33B | |
-12.62% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.66% | 17.64B | |
+4.36% | 14.05B | |
+35.09% | 12.51B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Cue Biopharma Says Phase 1b Trial of CUE-101 With Pembrolizumab Shows 40% Overall Response Rate